Early oxidative stress in the diabetic kidney: Effect of DL-α-lipoic acid

Free Radical Biology and Medicine

Volumn 34, Issue 2, 2003, Pages 186-195

  Obrosova, Irina G ^a   Fathallah, Lamia ^a   Liu, Edwin ^b   Nourooz Zadeh, Jaffar ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

4 Hydroxyalkenals; Antioxidative enzymes; Ascorbate; F2 isoprostanes; Free radicals; Glutathione; Malondialdehyde; Rat; Renal cortex; Streptozotocin diabetes

Indexed keywords

4 HYDROXYALKENAL; ALDEHYDE DERIVATIVE; ARACHIDONIC ACID; ASCORBIC ACID; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; ISOPROSTANE; MALONALDEHYDE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME REGULATION; GAS CHROMATOGRAPHY; KIDNEY CORTEX; MALE; MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL;

ALBUMINURIA; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS; F2-ISOPROSTANES; KIDNEY CORTEX; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOCTIC ACID;

EID: 0037438946     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01195-4     Document Type: Article

References (84)

1. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 18:1995;258-268.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329:1993;977-986.
3. Horie K., Miyata T., Maeda K., Miyata S., Sugiyama S., Sakai H., Strihou C.Y., Monnier V.M., Witztum J.L., Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest. 100:1997;2995-3004.
4. Reddi A.S., Bollineni J.S. Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochem. Biophys. Res. Commun. 235:1997;598-601.
5. Dobashi K., Asayama K., Hayashibe H., Uchida N., Kobayashi M., Kawaoi A., Kato K. Effect of diabetes mellitus induced by streptozotocin on renal superoxide dismutases in the rat. A radioimmunoassay and immunohistochemical study. Virchows Archiv. B. Cell Pathol. Incl. Mol. Pathol. 60:1991;67-72.
6. Schnackenberg C.G., Wilcox C.S. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int. 59:2001;1859-1864.
7. Cooper M.E. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia. 44:2001;1957-1972.
8. Melhem M.F., Craven P.A., Liachenko J., DeRubertis F.R. Alpa-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial expansion in diabetes. J. Am. Soc. Nephrol. 13:2002;108-116.
9. Lal M.A., Korner A., Matsuo Y., Zelenin S., Cheng S.X., Jaremko G., DiBona G.F., Eklof A.C., Aperia A. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes. 49:2000;1381-1389.
10. Melhem M.F., Craven P.A., DeRubertis F.R. Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J. Am. Soc. Nephrol. 12:2001;124-133.
11. Trachtman H., Futterweit S., Maesaka J., Ma C., Valderrama E., Fuchs A., Tarectecan A.A., Rao P.S., Sturman J.A., Boles T.H. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am. J. Physiol. 269:1995;F429-F438.
12. Soulis-Liparota T., Cooper M.E., Dunlop M., Jerums G. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia. 38:1995;387-394.
13. Agardh, C. D.; Senram, U.; Torffvit, O.; Agardh, E. Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J. Diabetes Complications In press.
14. Rungby J., Flyvbjerg A., Andersen H.B., Nyborg K. Lipid peroxidation in early experimental diabetes in rats effects of diabetes and insulin . Acta Endocrinol. (Copenh.). 126:1992;378-380.
15. Lubec B., Hermon M., Hoeger H., Lubec G. Aromatic hydroxylation in animal models of diabetes mellitus. FASEB J. 12:1998;1581-1587.
16. Kedziora-Kornatowska K. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats. Clin. Chim. Acta. 287:1999;19-27.
17. Nishikawa T., Edelstein D., Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int. 58:(Suppl. 77):2000;26-30.
18. Mano T., Shinohara R., Nagasaka A., Nakagawa H., Uchimura K., Hayashi R., Nakano I., Tsugawa T., Watanabe F., Kobayashi T., Fujiwara K., Nakai A., Itoh M. Scavenging effect of nicorandil on free radicals and lipid peroxide in streptozotocin-induced diabetic rats. Metabolism. 49:2000;427-431.
19. Kakkar R., Mantha S.V., Radhi J., Prasad K. Kalra, J. Antioxidant defense system in diabetic kidney a time course study . Life Sci. 60:1997;667-679.
20. Matkovics B., Kotorman M., Varga I.S., Hai D.Q., Varga C. Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol. Hung. 85:1997-98;29-38.
21. Aragno M., Tamagno E., Gatto V., Brignardello E., Parola S., Danni O., Boccuzzi G. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic. Biol. Med. 26:1999;1467-1474.
22. Braunlich H., Marx F., Stein G. Glutathione status, lipid peroxidation and kidney function in streptozotocin diabetic rats. Exp. Toxicol. Pathol. 46:1994;143-147.
23. Volkovova K., Chorvathova V., Jurcovicova M., Koszeghyova L., Bobek P. Antioxidative state of the myocardium and kidneys in acute diabetic rats. Physiol. Res. 42:1993;251-255.
24. Irizar A., Ioannides C. Extrahepatic expression of P450 proteins in insulin-dependent diabetes mellitus. Xenobiotica. 25:1995;941-949.
25. Mak D.H., Ip S.P., Li P.C., Poon M.K., Ko K.M. Alterations in tissue glutathione antioxidant system in streptozotocin-induced diabetic rats. Mol. Cell. Biochem. 162:1996;153-158.
26. Rauscher F.M., Sanders R.A., Watkins J.B. 3rd. Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 14:2000;329-334.
27. Kurusu A., Shou I., Nakamura S., Fukui M., Shirato I., Tomino Y. Effects of the new hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on anti-oxidant enzyme activities and renal function in streptozotocin-induced diabetic rats. Clin. Exp. Pharmacol. Physiol. 27:2000;767-770.
28. Reddi A.S., Bollineni J.S. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. Kidney Int. 59:2001;1342-1353.
29. Lindsay R.M., Jamieson N.S., Walker S.A., McGuigan C.C., Smith W., Baird J.D. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes. Diabetologia. 41:1998;516-523.
30. Packer L., Witt E.H., Tritschler H.J. α-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19:1995;227-250.
31. Maitra I., Serbinova E., Trischler H., Packer L. α-Lipoic acid prevents buthionine-sulfoximine-induced cataract formation in newborn rats. Free Radic. Biol. Med. 18:1995;823-829.
32. Obrosova I., Cao X., Greene D.A., Stevens M.J. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism effect of DL-alpha-lipoic acid . Diabetologia. 41:1998;1442-1450.
33. Obrosova I.G., Fathallah L., Greene D.A. Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina effect of DL-alpha-lipoic acid . Eur. J. Pharmacol. 398:2000;139-146.
34. Obrosova I.G., Minchenko A.G., Marinescu V., Fathallah L., Kennedy A., Stockert C.M., Frank R.N., Stevens M.J. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia. 44:2001;1102-1110.
35. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock D.A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
36. Stevens M.J., Obrosova I., Cao X., Van Huysen C., Greene D.A. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes. 49:2000;1006-1015.
37. Keegan A., Cotter M.A., Cameron N.E. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia. 42:1999;343-350.
38. Garrett N.E., Malcangio M., Dewhurst M., Tomlinson D.R. alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci. Lett. 222:1997;191-194.
39. Cameron N.E., Cotter M.A., Horrobin D.H., Tritschler H. J. Effects of alpha-lipoic acid on neurovascular function in diabetic rats interaction with essential fatty acids . Diabetologia. 41:1998;390-399.
40. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., Lund D.D., Yorek M.A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes. 50:2001;1927-1937.
41. Borenshtein D., Ofri R., Werman M., Stark A., Tritschler H.J., Moeller W., Madar Z. Cataract development in diabetic sand rats treated with alpha-lipoic acid and its gamma-linolenic acid conjugate. Diabetes Metab. Res. Rev. 17:2001;44-50.
42. Morcos M., Borcea V., Isermann B., Gehrke S., Ehret T., Henkels M., Schiekofer S., Hofmann M., Amiral J., Tritschler H., Ziegler R., Wahl P., Nawroth P.P. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus an exploratory study . Diabetes Res. Clin. Pract. 52:2001;175-183.
43. 2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 348:1994;297-300.
44. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry development of a solid-phase extraction procedure . J. Chromatogr. B Biomed. Appl. 667:1995;199-208.
45. Nourooz-Zadeh J., Pereira P. F(2) isoprostanes, potential specific markers of oxidative damage in human retina. Ophthalmic Res. 32:2000;133-137.
46. Nourooz-Zadeh J., Pereira P. Age-related accumulation of free polyunsaturated fatty acids in human retina. Ophthalmic Res. 31:1999;273-279.
47. Ho E., Chen G., Bray T.M. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes. Free Radic. Biol. Med. 28:2000;604-614.
48. Chen H.C., Guh J.Y., Shin S.J., Tsai J.H., Lai Y.H. Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein. Kidney Int. 78:(Suppl.):2001;S124-S127.
49. Van Dam P.S., Bravenboer B., van Asbeck B.S., van Oirschot J.F., Marx J.J., Gispen W.H. Effects of insulin treatment on endoneurial and systemic oxidative stress in relation to nerve conduction in streptozotocin-diabetic rats. Eur. J. Clin. Invest. 26:1996;1143-1149.
50. Kakimoto M., Inoguchi T., Sonta T., Yu H.Y., Imamura M., Etoh T., Hashimoto T., Nawata H. Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes. 51:2002;1588-1595.
51. Hayashi K., Haneda M., Koya D., Maeda S., Isshiki K., Kikkawa R. Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res. Clin. Pract. 52:2001;85-96.
52. Saito H. Biochemical changes in lens, aqueous humor and vitreous body and effects of aldose reductase inhibitor (TAT) on rats with experimental diabetes. Nippon Ika Daigaku Zasshi. 62:1995;339-350.
53. Lowitt S., Malone J.I., Salem A.F., Korthals J., Benford S. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism. 44:1995;677-680.
54. Lou M.F., Dickerson J.E. Jr., Garadi R., York B.M. Jr. Glutathione depletion in the lens of galactosemic and diabetic rats. Exp. Eye Res. 46:1988;517-530.
55. Cameron N.E., Cotter M.A., Jack A.M., Basso M.D., Hohman T.C. Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats. Diabetologia. 42:1999;1120-1130.
56. Naveh-Floman N., Weissman C., Belkin M. Arachidonic acid metabolism by retinas of rats with streptozotocin-induced diabetes. Curr. Eye Res. 3:1984;1135-1139.
57. Bose R., Sutherland G.R., Pinsky C. Biological and methodological implications of prostaglandin involvement in mouse brain lipid peroxidation measurements. Neurochem. Res. 14:1989;217-220.
58. Dannhardt G., Flemmer L., Hartmann R.W., Kleber A., Schulze E. Spectrofluorimetric quantification of malondialdehyde for evaluation of cyclooxygenase-1/thromboxane synthase inhibition. Arch. Pharm. (Weinheim). 331:1998;359-364.
59. Miinea C., Kuruvilla R., Merrikh H., Eichberg J. Altered arachidonic acid biosynthesis and antioxidant protection mechanisms in Schwann cells grown in elevated glucose. J. Neurochem. 81:2002;1253-1262.
60. Tajiri Y., Umeda F., Inoguchi T., Nawata H. Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat. J. Diabetes Complications. 8:1994;126-132.
61. Raza H., Ahmed I., John A., Sharma A.K. Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. J. Biochem. Mol. Toxicol. 14:2000;131-139.
62. 1-adrenoceptor antagonist on nerve function, metabolism and antioxidative defense. FASEB J. 14:2000;1548-1558.
63. Obrosova I.G., Fathallah L., Lang H.J. Interaction between osmotic and oxidative stress in diabetic precataractous lens. Studies with a sorbitol dehydrogenase inhibitor. Biochem. Pharmacol. 58:1999;1945-1954.
64. Kador P.F. The role for aldose reductase in the development of diabetic complications. Med. Res. Rev. 8:1988;325-352.
65. Obrosova I., Faller A., Burgan J., Ostrow E., Williamson J.R. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats effect of an aldose reductase inhibitor . Curr. Eye Res. 16:1997;34-43.
66. Obrosova I.G., Fathallah L. Evaluation of an aldose reductase inhibitor on lens metabolism, ATP-ases and antioxidative defense an intervention study . Diabetologia. 43:2000;1048-1055.
67. Obrosova I.G., Van Huysen C., Fathallah L., Cao X., Greene D.A., Stevens M.J. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J. 16:2002;123-125.
68. Lee A.Y.W., Chung S.S.M. Contribution of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 13:1999;23-30.
69. Ho E.C.M., Lam K.S.L., Chung S.S.M. Aldose reductase-deficient mice are protected from reduction of nerve conduction associated with diabetes. J. Periph. Nerv. Syst. 5:2000;169-188.
70. Obrosova I.G., Li F., White L., Abatan O.I., Szabo C., Stevens M.J. Poly(ADP-ribose)synthetase-knockout mice are protected from functional and biochemical deficits associated with early diabetes-like neuropathy. Diabetes. 51:(Suppl. 2):2002;A206.
71. Khanna P., Wang L., Perez-Polo R.J., Ansari N.H. Oxidative defense enzyme activity and mRNA levels in lenses of diabetic rats. J. Toxicol. Environ. Health. 51:1997;541-555.
72. Obrosova I.G., Greene D.A., Lang H.J. Antioxidative defense in diabetic peripheral nerve: effect of DL-α-lipoic acid, aldose reductase inhibitor and sorbitol dehydrogenase inhibitor. Packer L., Roesen P., Tritschler H., King G., Azzi A. Antioxidants in diabetes management. 2000;93-110 Marcel Dekker, New York.
73. Kakkar R., Kalra J., Mantha S.V., Prasad K. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol. Cell. Biochem. 151:1995;113-119.
74. Rauscher F.M., Sanders R.A., Watkins J.B. 3rd. Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 15:2001;159-164.
75. Sanders R.A., Rauscher F.M., Watkins J.B. 3rd. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 15:2001;143-149.
76. Roy S., Sen C.K., Tritschler H.J. Packer, L. Modulation of cellular reducing equivalent homeostasis by alpha-lipoic acid. Mechanisms and implications for diabetes and ischemic injury. Biochem. Pharmacol. 53:1997;393-399.
77. Sen C.K. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55:1998;1747-1758.
78. Obrosova I.G., Stevens M.J., Lang H.J. Diabetes-induced changes in retinal NAD-redox status pharmacological modulation and implications for pathogenesis of diabetic retinopathy . Pharmacology. 62:2001;172-180.
79. Konrad D., Somwar R., Sweeney G., Yaworsky K., Hayashi M., Ramlal T., Klip A. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation potential role of p38 mitogen-activated protein kinase in GLUT4 activation . Diabetes. 50:2001;1464-1471.
80. Moini H., Tirosh O., Park Y.C., Cho K.J., Packer L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 397:2002;384-391.
81. Jacob S., Streeper R.S., Fogt D.L., Hokama J.Y., Tritschler H.J., Dietze G.J., Henriksen E.J. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes. 45:1996;1024-1029.
82. Maitra I., Serbinova E., Tritschler H.J., Packer L. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats. Biochem. Biophys. Res. Commun. 221:1996;422-429.
83. Kilic F., Handelman G.J., Traber K., Tsang K., Packer L., Trevithick J.R. Modelling cortical cataractogenesis XX. In vitro effect of alpha-lipoic acid on glutathione concentrations in lens in model diabetic cataractogenesis. Biochem. Mol. Biol. Int. 46:1998;585-595.
84. Lockhart B., Jones C., Cuisinier C., Villain N., Peyroulan D., Lestage P. Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with alpha-lipoic acid enantiomers. Brain Res. 855:2000;292-297.